Interestingly, subjects with biallelic HARS2 pathogenic variants, like the five reported in this study, do not show neurological signs [26] or they may be very subtle [17,28], in contrast to what is observed for other genes involved in Perrault syndrome [26]. This evidence concerns the gene HARS2 and Perrault syndrome.